• NovaBridge Biosciences filed an initial statement of beneficial ownership naming Lei Ming Kyler as Chief Financial Officer.
• Lei Ming Kyler reported a 2025 Employee Share Option covering 996,775 ordinary shares.
• The option has an exercise price of USD 4.25 and an expiration date of 10/16/2035.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-114832), on March 18, 2026, and is solely responsible for the information contained therein.